Endorphin deficiency syndrome (EDS) is a condition where low levels of natural opioids in the brain contribute to addictive behaviors. Endorphins play a vital role in regulating pain, stress, and mood. When deficient, individuals may turn to substances like alcohol or opioids to compensate, leading to dependency. This biological predisposition highlights the neurochemical foundation of addiction. Treatments often involve therapies that stimulate endorphin production, such as exercise, acupuncture, and certain antidepressants. Recognizing EDS in addiction patients is crucial for developing tailored interventions that address this underlying imbalance, improving treatment outcomes and reducing the likelihood of relapse.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Genetic decoupling and global regulatory failure in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : An unusual perspective for understanding and preventing bulimia relapse: Unhealthy sibling loyalty
Karen Gail Lewis, Private Practice, United States